ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,844Medicare Part D Prescriptions Filled, Including Refills

Rank: 450 out of 3734

$501K Total Retail Price of All Prescriptions

Rank: 712 out of 3734

594 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 594 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 594 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 10,455 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL SUCCINATE 439 426 1 14
OMEPRAZOLE 438 429 2 4
CITALOPRAM HBR 384 369 3 16
LEVOTHYROXINE SODIUM 370 358 4 2
GABAPENTIN 284 271 5 17
FUROSEMIDE 276 275 6 7
SERTRALINE HCL 237 227 7 18
ALLOPURINOL 216 213 8 33
AMLODIPINE BESYLATE 201 200 9 5
HYDROCHLOROTHIAZIDE 200 188 10 9
LIDOCAINE HCL 199 187 11 284
ATORVASTATIN CALCIUM 186 174 12 11
TRAZODONE HCL 177 176 13 49
LOSARTAN POTASSIUM 160 160 14 21
ATENOLOL 156 156 15 13
LISINOPRIL 148 141 16 3
TAMSULOSIN HCL 145 145 17 29
SIMVASTATIN 145 131 17 1
JANTOVEN 133 132 19 76
MIRTAZAPINE 127 126 20 45
HYDROCODONE-ACETAMINOPHEN 126 125 S3 21 12
CYMBALTA 115 112 22 67
BUMETANIDE 113 113 23 78
LEVOXYL 113 113 23 190
DONEPEZIL HCL 113 101 23 25
CARVEDILOL 109 109 26 30
METOPROLOL TARTRATE 106 106 27 6
DIOVAN 105 92 28 31
KETOCONAZOLE 99 95 29 204
CARBIDOPA-LEVODOPA 96 95 30 92
OLANZAPINE 94 94 31 106
ENALAPRIL MALEATE 87 87 32 63
POLYETHYLENE GLYCOL 3350 84 75 33 53
NAMENDA 83 83 34 44
PANTOPRAZOLE SODIUM 82 67 35 22
LAMOTRIGINE 81 81 36 169
DIVALPROEX SODIUM 81 67 36 99
SPIRONOLACTONE 74 74 38 80
VENLAFAXINE HCL ER 73 73 39 84
WARFARIN SODIUM 73 73 39 10
FINASTERIDE 71 71 41 88
ESCITALOPRAM OXALATE 70 70 42 68
BUPROPION HCL SR 69 69 43 165
LANTUS 67 62 44 54
PREDNISONE 67 66 44 42
POTASSIUM CHLORIDE 64 64 46 19
SPIRIVA 64 63 46 40
CLOPIDOGREL 63 62 48 23
QUETIAPINE FUMARATE 62 62 49 82
OXYCONTIN 60 59 S2 50 121
ERYTHROMYCIN 56 56 51 327
BENAZEPRIL HCL 55 55 52 103
TRIAMCINOLONE ACETONIDE 55 48 52 131
ISOSORBIDE MONONITRATE ER 54 54 54 34
METOLAZONE 53 53 55 174
RANITIDINE HCL 52 52 56 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.